OmniStar Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
8,487
+647
+8% +$151K 0.99% 32
2026
Q1
$1.92M Sell
7,840
-17,329
-69% -$4.04M 0.99% 31
2025
Q4
$5.21M Buy
25,169
+1,518
+6% +$300K 3.05% 6
2025
Q3
$4.39M Buy
23,651
+56
+0.2% +$9.59K 2.66% 6
2025
Q2
$3.6M Buy
23,595
+11,837
+101% +$1.82M 2.7% 5
2025
Q1
$1.96M Buy
11,758
+7,977
+211% +$1.25M 1.54% 16
2024
Q4
$547K Sell
3,781
-938
-20% -$145K 0.44% 75
2024
Q3
$769K Sell
4,719
-4,444
-48% -$708K 0.58% 59
2024
Q2
$1.34M Buy
9,163
+896
+11% +$133K 1.21% 18
2024
Q1
$1.31M Buy
8,267
+4,391
+113% +$699K 1.2% 19
2023
Q4
$608K Sell
3,876
-446
-10% -$68.4K 0.76% 47
2023
Q3
$675K Buy
4,322
+16
+0.4% +$2.64K 0.8% 42
2023
Q2
$713K Buy
4,306
+416
+11% +$67.1K 0.84% 42
2023
Q1
$603K Sell
3,890
-31
-0.8% -$5.01K 0.77% 50
2022
Q4
$693K Buy
3,921
+80
+2% +$13.8K 0.79% 50
2022
Q3
$627K Buy
3,841
+258
+7% +$43.7K 0.75% 50
2022
Q2
$636K Sell
3,583
-34
-0.9% -$6.06K 0.7% 54
2022
Q1
$641K Sell
3,617
-572
-14% -$97.3K 0.64% 61
2021
Q4
$716K Buy
4,189
+517
+14% +$84.6K 0.73% 58
2021
Q3
$593K Buy
+3,672
New +$626K 0.7% 58
2021
Q2
Sell
-4,633
Closed -$767K 139
2021
Q1
$761K Sell
4,633
-2,831
-38% -$458K 0.97% 37
2020
Q4
$1.18M Buy
7,464
+3,036
+69% +$448K 0.82% 45
2020
Q3
$659K Sell
4,428
-1,602
-27% -$237K 0.5% 62
2020
Q2
$848K Sell
6,030
-8,907
-60% -$1.3M 0.7% 53
2020
Q1
$1.96M Sell
14,937
-840
-5% -$119K 1.93% 13
2019
Q4
$2.3M Sell
15,777
-162
-1% -$22K 1.94% 12
2019
Q3
$2.06M Buy
15,939
+243
+2% +$32K 1.8% 13
2019
Q2
$2.19M Sell
15,696
-187
-1% -$25.9K 1.96% 10
2019
Q1
$2.22M Buy
15,883
+673
+4% +$90.1K 1.95% 10
2018
Q4
$1.96M Sell
15,210
-475
-3% -$66.3K 2% 13
2018
Q3
$2.17M Sell
15,685
-1,070
-6% -$142K 1.65% 14
2018
Q2
$2.03M Buy
16,755
+1,123
+7% +$140K 1.94% 13
2018
Q1
$2M Sell
15,632
-8,934
-36% -$1.21M 1.91% 14
2017
Q4
$3.42M Buy
+24,566
New +$3.42M 3.13% 3

Other funds holding JNJ

OmniStar Financial Group's JNJ Position: Q2 2026 in Review

OmniStar Financial Group increased its Johnson & Johnson (JNJ) stake by 8.3% in Q2 2026, buying an estimated $151K and bringing the position to 8,487 shares worth $2.16M. The position accounts for 0.99% of the portfolio, ranked #32.

OmniStar Financial Group first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.21M in Q4 2025. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • OmniStar Financial Group held 8,487 shares of Johnson & Johnson worth $2.16M as of Q2 2026.
  • OmniStar Financial Group bought 647 Johnson & Johnson shares in Q2 2026, an estimated $151K.
  • Johnson & Johnson made up 0.99% of OmniStar Financial Group's portfolio in Q2 2026, its #32 holding.
  • OmniStar Financial Group first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • OmniStar Financial Group's Johnson & Johnson position peaked at $5.21M in Q4 2025.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on OmniStar Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.